1 Result(s)

Article

Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis

Despite vaccine availability, influenza remains a substantial global public health concern. Here, we report interim findings on the primary and secondary objectives of the safety, reactogenicity, and humoral i...

Ivan T. Lee, Raffael Nachbagauer, David Ensz, Howard Schwartz… in Nature Communications (2023)